Huadong Medicine Presents DR10624 Study Results for Obesity and Hypertriglyceridemia at EASL 2025
China-based Huadong Medicine Co., Ltd (SHE: 000963) announced the first presentation of results from its...
Teva Announces 8% Workforce Reduction to Achieve $700 Million Cost-Saving Goal
Israel-based Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has disclosed plans to reduce its workforce by...
Formosa Pharmaceuticals Signs Licensing Deal with Laboratorios Saval for APP13007
Taiwan-based Formosa Pharmaceuticals (TPE: 6838) announced a licensing agreement with Laboratorios Saval, granting the Chilean...
Hybio Partners with iCarbonX to Develop Triple Agonist for Metabolic Diseases
China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) announced a strategic partnership with compatriot firm iCarbonX...
Tenacia Partners with TSH Biopharm for Ztalmy Commercialization in Taiwan
Tenacia Biotechnology, a central nervous system (CNS) specialist backed by Bain Capital, has entered into...
BeiGene’s Sonrotoclax Gains NMPA Priority Review for MCL Treatment
BeiGene, Ltd. (NASDAQ: ONC, HKG: 6160, SHA: 688235), a China-based oncology specialist proposing to change...
United Imaging Healthcare Gains FDA Approval for uAngio AVIVA Interventional X-ray System
China-based United Imaging Healthcare (UIH, SHA: 688271) announced that it has received marketing approval from...
Trump Executive Order Seeks to Align US Prescription Drug Prices with Global Standards
U.S. President Donald J. Trump has signed an executive order aimed at aligning prescription drug...
Fosun Pharma’s FCN-159 Granted Breakthrough Therapy Designation for Pediatric LCH
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) announced that its novel small-molecule...
Merck Sharp & Dohme Launches Recarbrio in China for Bacterial Pneumonia and Infections
US-based pharmaceutical giant Merck, Sharp & Dohme Inc. (MSD; NYSE: MRK) has announced the official...
Roche Invests $550 Million in Indianapolis Diagnostics Facility for CGM Systems
Swiss giant Roche (SWX: ROG, OTCMKTS: RHHBY) announced plans to invest up to USD 550...
RemeGen’s Disitamab Vedotin Phase III Study Meets PFS and OS Endpoints
China-based RemeGen Ltd (HKG: 9995) announced that its Phase III clinical study for the antibody...
Eastenova Biotechnology Makes Hong Kong IPO Debut With Regenerative Medicine Focus
China-based Eastenova (Chengdu) Biotechnology Co., Ltd. this week made an initial public offering (IPO) to...
AstraZeneca’s Trixeo Aerosphere Wins UK Approval for COPD
UK-based pharmaceutical giant AstraZeneca (AZ; NASDAQ: AZN) announced this week that it has received marketing...
Grand Pharma Completes Patient Enrollment for TLX591-CDx Phase III Trial
Grand Pharmaceutical Group Limited (HKG: 0512) announced the completion of patient enrollment for the Phase...
Hengrui Pharmaceuticals Gains NMPA Clearance for SHR-1316 (sc) in ES-SCLC Trial
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) announced that it has received clearance from...
Fosun Pharma’s LBP-ShC4 Receives FDA Approval for Androgenic Alopecia Study
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (HKG: 2196, SHA: 600196) announced that it has...
MicroPort’s Talos Stent Gains Marketing Approval in Argentina
Shanghai MicroPort Endovascular MedTech Co., Ltd (SHA: 688016) announced that it has received marketing approval...
Hainan Unveils 20 Measures to Boost Pharmaceutical Industry Reform and Quality
The General Office of the People’s Government of Hainan Province has released the “Implementation Plan...
Minghui Pharmaceutical Signs Licensing Deal with Qilu for B7-H3 ADC Development
China-based Minghui Pharmaceutical has entered into an exclusive licensing and collaboration agreement with Qilu Pharmaceutical....